BSE Live
Feb 20, 16:01Prev. Close
226.60
Open Price
225.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Feb 20, 15:58Prev. Close
226.47
Open Price
225.10
Bid Price (Qty.)
223.26 (2142)
Offer Price (Qty.)
0.00 (0)
| Cash Flow of Bliss GVS Pharma (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 94.17 | 111.34 | 115.69 | 123.66 | 91.19 | |
| Net CashFlow From Operating Activities | 97.21 | 125.92 | 43.81 | 114.05 | 66.97 | |
| Net Cash Used In Investing Activities | -77.73 | -109.59 | -12.97 | -92.28 | -61.62 | |
| Net Cash Used From Financing Activities | -26.71 | -20.76 | -26.05 | -12.62 | -11.67 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | -7.23 | -4.43 | 4.79 | 9.14 | -6.33 | |
| Cash And Cash Equivalents Begin of Year | 14.17 | 18.60 | 13.82 | 4.67 | 11.00 | |
| Cash And Cash Equivalents End Of Year | 6.95 | 14.17 | 18.60 | 13.82 | 4.67 |
20.02.2026
Bliss GVS Consolidated December 2025 Net Sales at Rs 218.25 crore, up 3.72% Y-o-Y
19.02.2026
Bliss GVS Standalone December 2025 Net Sales at Rs 164.68 crore, down 8.3% Y-o-Y
07.11.2025
Bliss GVS Consolidated September 2025 Net Sales at Rs 244.40 crore, up 12.27% Y-o-Y
30.07.2025
Bliss GVS Consolidated June 2025 Net Sales at Rs 207.47 crore, up 12.97% Y-o-Y